VEGFA and neoplasm: In RIP-Tag2 mice treated with drugs targeting VEGF or VEFGR2, tumor cells rapidly develop ‘evasive resistance’ marked by increased invasiveness with peri-pancreatic lymph node and liver metastases [200].